n-methyl-3,4-methylenedioxyamphetamine has been researched along with n,n-dimethyl-2-(2-amino-4-fluorophenylthio)benzylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CY; Chen, YA; Cheng, CY; Huang, SY; Huang, WS; Li, IH; Lin, YS; Liu, RS; Ma, KH; Shiue, CY; Wang, SJ | 1 |
| Chen, CF; Cheng, CY; Huang, YS; Li, IH; Ma, KH; Pao, LH; Shih, JH; Shiue, CY; Weng, SJ; Yeh, MK | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and n,n-dimethyl-2-(2-amino-4-fluorophenylthio)benzylamine
| Article | Year |
|---|---|
Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study.
Topics: Animals; Benzylamines; Brain; Female; Fluorine Radioisotopes; Fluoxetine; Macaca; Male; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tissue Distribution | 2012 |
Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
Topics: Animals; Benzylamines; Brain; Brain Mapping; Corticosterone; Depressive Disorder; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats, Sprague-Dawley; Resveratrol; RNA-Binding Proteins; Serotonin Agents; Stilbenes | 2016 |